Izzy Boyfield
GlaxoSmithKline (United Kingdom)(GB)
Publications by Year
Research Areas
Receptor Mechanisms and Signaling, Neurotransmitter Receptor Influence on Behavior, Neuroscience and Neuropharmacology Research, Synthesis and Reactivity of Heterocycles, Adenosine and Purinergic Signaling
Most-Cited Works
- → Pharmacological Actions of a Novel, High-Affinity, and Selective Human Dopamine D3 Receptor Antagonist, SB-277011-A(2000)288 cited
- → TRPM2 channel opening in response to oxidative stress is dependent on activation of poly(ADP‐ribose) polymerase(2004)283 cited
- → Amyloid β‐peptide(1–42) and hydrogen peroxide‐induced toxicity are mediated by TRPM2 in rat primary striatal cultures(2005)200 cited
- → The C-Terminal Domains of the GABABReceptor Subunits Mediate Intracellular Trafficking But Are Not Required for Receptor Signaling(2001)159 cited
- → Design and Synthesis of trans-N-[4-[2-(6-Cyano-1,2,3,4-tetrahydroisoquinolin-2- yl)ethyl]cyclohexyl]-4-quinolinecarboxamide (SB-277011): A Potent and Selective Dopamine D3 Receptor Antagonist with High Oral Bioavailability and CNS Penetration in the Rat(2000)129 cited
- → Comparison of the functional potencies of ropinirole and other dopamine receptor agonists at human D2(long), D3 and D4.4 receptors expressed in Chinese hamster ovary cells(1999)76 cited
- → Design and Synthesis oftrans-3-(2-(4-((3-(3-(5-Methyl-1,2,4-oxadiazolyl))- phenyl)carboxamido)cyclohexyl)ethyl)-7-methylsulfonyl-2,3,4,5-tetrahydro- 1H-3-benzazepine (SB-414796): A Potent and Selective Dopamine D3Receptor Antagonist(2003)72 cited
- → Evidence for antagonist activity of the dopamine D3 receptor partial agonist, BP 897, at human dopamine D3 receptor(2000)64 cited
- → Pharmacological characterization of extracellular acidification rate responses in human D2(long), D3 and D4.4 receptors expressed in Chinese hamster ovary cells(1999)52 cited
- → Molecular cloning and characterisation of a novel GABAB-related G-protein coupled receptor(2003)51 cited